Today RMS is proud to announce the partnership with CoreLine, one of the leading Thoracic Imaging AI solution providers.

After the successful launch of its Breast Health AI Platform (Profound AI) in Benelux, RMS is now expanding the Medical Imaging AI devision with a dedicated portfolio of CHEST AI solutions in collaboration with Coreline Soft.

Coreline Soft Ltd. was founded in 2012 and has its headquarter in Seoul, South Korea.

Recently CLS founded Coreline Europe GmbH in Frankfurt, Germany and in March 2021 a partnership was officialized between CLS and RMS Medical Devices in order to support the fast-growing European business.

Coreline Soft develops AI based thorax specialized imaging diagnosis solutions, lung cancer screening (LCS), COPD quantification, and coronary artery calcification (CAC). These modules, so called “Big3”, cover the three big diseases of thoracic imaging.

More complex lung modules are being added to the platform, such as texture analysis for ILD/IPF and pneumonia detection including COVID-19.

Coreline Soft became official solution provider of 4-IN-THE-LUNG-RUN (4ITLR) project, initiated and led by the Nelson Team (Erasmus MC and iDNA in the Netherlands). 4-IN-THE-LUNG-RUN has set up the goal to establish strategies that lead to cost-efficient lung cancer screening within reach for Europe.

"We strongly believe that Coreline´s AI technology will bring added value to the users and patients by preventing and early diagnosing the “Big3” thorax diseases, especially lung cancer." says Olivier Wouters from RMS Medical Devices

"We aim to contribute to a reduction of lung cancer-related mortality not only in Europe, but hopefully world-wide." states Vanja Azabagic-Thursar from Coreline Europe GmbH.

For more information, please do not hesitate to contact your RMS Product Consultant directly or send your inquiries to sales@rmsmedicaldevices.com